Zhao Huang

6.3k total citations · 7 hit papers
60 papers, 4.1k citations indexed

About

Zhao Huang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zhao Huang has authored 60 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 21 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Zhao Huang's work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (7 papers) and Autophagy in Disease and Therapy (6 papers). Zhao Huang is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (7 papers) and Autophagy in Disease and Therapy (6 papers). Zhao Huang collaborates with scholars based in China, Australia and United States. Zhao Huang's co-authors include Canhua Huang, Edouard C. Nice, Na Xie, Li Fu, Wei Gao, Li Zhou, Guobo Shen, Yong Peng, Siyuan Qin and Bowen Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Zhao Huang

59 papers receiving 4.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoantigens: promising targets for cancer therapy

2023 536 citations Na Xie, Zhao Huang et al. Signal Transduction and Targeted Therapy profile →
The role of long noncoding RNAs in hepatocellular carcinoma

2020 360 citations Zhao Huang, Yong Peng et al. profile →
Oral squamous cell carcinomas: state of the field and emerging directions

2023 320 citations Bowen Li, Zhao Huang et al. profile →
From purines to purinergic signalling: molecular functions and human diseases

2021 287 citations Zhao Huang, Na Xie et al. Signal Transduction and Targeted Therapy profile →
Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies

2022 283 citations Siyuan Qin, Zhao Huang et al. Journal of Hematology & Oncology profile →
Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A

2021 236 citations Zhao Huang, Jiufei Duan et al. profile →
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management

2022 152 citations Ping Jin, Jingwen Jiang et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhao Huang China	28	2.1k	1.2k	931	573	507	60	4.1k
Wei Qiu China	40	2.5k 1.2×	1.1k 0.9×	860 0.9×	691 1.2×	449 0.9×	112	4.3k
Shengli Yang China	33	2.0k 1.0×	845 0.7×	1.0k 1.1×	480 0.8×	429 0.8×	167	4.0k
Xiao Zhu China	39	3.1k 1.5×	1.7k 1.4×	1.2k 1.3×	759 1.3×	557 1.1×	136	5.5k
Wei Yan China	39	3.2k 1.5×	974 0.8×	736 0.8×	705 1.2×	297 0.6×	118	4.6k
Ying Zhang China	40	3.5k 1.6×	1.2k 1.0×	1.8k 1.9×	637 1.1×	455 0.9×	258	6.2k
Emilia Wiecheć Sweden	29	2.1k 1.0×	815 0.7×	1.1k 1.1×	321 0.6×	383 0.8×	46	3.7k
Tao Ning China	33	2.5k 1.2×	1.6k 1.4×	835 0.9×	580 1.0×	413 0.8×	151	4.4k
Bin Yan China	38	2.8k 1.3×	1.5k 1.3×	899 1.0×	692 1.2×	294 0.6×	179	4.9k
Muzafar A. Macha India	35	2.4k 1.1×	1.2k 1.0×	1.2k 1.3×	508 0.9×	283 0.6×	90	4.0k
Xi Yang China	33	2.1k 1.0×	1.2k 1.1×	826 0.9×	321 0.6×	291 0.6×	197	4.2k

Countries citing papers authored by Zhao Huang

Since Specialization

Citations

This map shows the geographic impact of Zhao Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhao Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhao Huang more than expected).

Fields of papers citing papers by Zhao Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhao Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhao Huang. The network helps show where Zhao Huang may publish in the future.

Co-authorship network of co-authors of Zhao Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhao Huang. A scholar is included among the top collaborators of Zhao Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhao Huang. Zhao Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jin, Ping, Zhao Huang, Yuan Dong, et al.. (2025). Nuclear receptors in health and disease: signaling pathways, biological functions and pharmaceutical interventions. Signal Transduction and Targeted Therapy. 10(1). 228–228. 2 indexed citations

He, Bo, Zhao Huang, Siyuan Qin, et al.. (2024). Enhanced SLC35B2/SAV1 sulfation axis promotes tumor growth by inhibiting Hippo signaling in HCC. Hepatology. 81(2). 436–452. 2 indexed citations

Huang, Zhao & Wei Zhao. (2024). KMT2C/D deficiency promotes breast cancer metastasis by regulating KDM6A‐mediated epigenetic remodeling. SHILAP Revista de lepidopterología. 3(4).

Huang, Zhao, Li Zhou, Jiufei Duan, et al.. (2024). Oxidative Stress Promotes Liver Cancer Metastasis via RNF25‐Mediated E‐Cadherin Protein Degradation. Advanced Science. 11(13). e2306929–e2306929. 19 indexed citations

Jiang, Jingwen, Hai‐Ning Chen, Ping Jin, et al.. (2023). Targeting PSAT1 to mitigate metastasis in tumors with p53-72Pro variant. Signal Transduction and Targeted Therapy. 8(1). 65–65. 27 indexed citations

Li, Bowen, Hui Ming, Siyuan Qin, et al.. (2023). HSPA8 Activates Wnt/β‐Catenin Signaling to Facilitate BRAF V600E Colorectal Cancer Progression by CMA‐Mediated CAV1 Degradation. Advanced Science. 11(3). e2306535–e2306535. 21 indexed citations

Li, Jian, Shirong Cai, Yongjian Zhou, et al.. (2022). Efficacy and Safety of Ripretinib in Chinese Patients with Advanced Gastrointestinal Stromal Tumors as a Fourth- or Later-Line Therapy: A Multicenter, Single-Arm, Open-Label Phase II Study. Clinical Cancer Research. 28(16). 3425–3432. 12 indexed citations

Qin, Siyuan, Zhe Zhang, Zhao Huang, et al.. (2022). CCT251545 enhances drug delivery and potentiates chemotherapy in multidrug-resistant cancers by Rac1-mediated macropinocytosis. Drug Resistance Updates. 66. 100906–100906. 12 indexed citations

Zhang, Yi, Qiong Li, Zhao Huang, et al.. (2022). Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies. Cancers. 14(19). 4568–4568. 88 indexed citations

10.

Jin, Ping, Jingwen Jiang, Li Zhou, et al.. (2022). Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. Journal of Hematology & Oncology. 15(1). 97–97. 152 indexed citations breakdown →

11.

Ye, Qin, Li Zhou, Ping Jin, et al.. (2021). Guaiazulene Triggers ROS-Induced Apoptosis and Protective Autophagy in Non-small Cell Lung Cancer. Frontiers in Pharmacology. 12. 621181–621181. 12 indexed citations

12.

Huang, Zhao, Na Xie, Péter Illés, et al.. (2021). From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy. 6(1). 162–162. 287 indexed citations breakdown →

13.

Lv, You, et al.. (2019). Electrocrystallization process of manganese oxide in graphene hydrogel. Electrochimica Acta. 321. 134661–134661. 2 indexed citations

14.

Zhou, Li, et al.. (2019). Molecular insights into cancer drug resistance from a proteomics perspective. Expert Review of Proteomics. 16(5). 413–429. 23 indexed citations

15.

Chen, Yan, Hai‐Ning Chen, Kui Wang, et al.. (2018). Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma. Journal of Hepatology. 70(1). 66–77. 155 indexed citations

16.

Jiang, Lan, Zhao Huang, Junhong Han, Jichun Shao, & Canhua Huang. (2018). Redox regulation of microRNAs in cancer. Cancer Letters. 418. 250–259. 40 indexed citations

17.

Chen, Hai‐Ning, Kefei Yuan, Na Xie, et al.. (2016). PDLIM1 Stabilizes the E-Cadherin/β-Catenin Complex to Prevent Epithelial–Mesenchymal Transition and Metastatic Potential of Colorectal Cancer Cells. Cancer Research. 76(5). 1122–1134. 93 indexed citations

18.

Dou, Qianhui, Hai‐Ning Chen, Kui Wang, et al.. (2016). Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer. Cancer Research. 76(15). 4457–4469. 191 indexed citations

19.

Chen, Gang, Jing Hu, Zhao Huang, Lijing Yang, & Min Chen. (2016). MicroRNA-1976 functions as a tumor suppressor and serves as a prognostic indicator in non-small cell lung cancer by directly targeting PLCE1. Biochemical and Biophysical Research Communications. 473(4). 1144–1151. 27 indexed citations

20.

Mujoo, Kalpana, Byung-Kwon Choi, Zhao Huang, Ningyan Zhang, & Zhiqiang An. (2014). Regulation of ERBB3/HER3 signaling in cancer. Oncotarget. 5(21). 10222–10236. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact